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Abstract
Invasive disease as a result of Campylobacter is rarely reported. We reviewed 46 cases of blood stream infection with Campylobacter in a
Danish population with complete follow-up. The incidence was 2.9 per 1 million person-years with a peak incidence in the age group
above 80 years. In the population, the ratio of notiﬁed bacteraemia/enteritis patients with Campylobacter infection was 0.004. Patients
with bacteraemia were older and had higher comorbidity, e.g. alcoholism, immunosuppression, previous gastrointestinal surgery or HIV
infection. We found 26% of blood isolates resistant to ciproﬂoxacin. The length of hospitalization was signiﬁcantly longer in bacteraemia
patients, whereas the outcome was favourable with 28-day mortality of 4% in bacteraemia patients and 1% in enteritis patients. None of
the bacteraemia patients relapsed within 365-day follow-up.
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Introduction
Campylobacter species (especially C. jejuni) are among the
most commonly identiﬁed bacterial causes of acute gastroen-
teritis. Unlike other enteric infections such as salmonellosis,
campylobacter infection is only rarely associated with sys-
temic invasive illness [1,2]. Earlier reports on invasive campy-
lobacteriosis were characterized by either a very limited
number of cases [3,4] or were from reference laboratories
with limited clinical information [5,6]. Bloodstream infection
with Campylobacter species has been reported in immune-
compromised patients and in the very young or very old
[7–9]. However, information concerning clinical and bacterio-
logical characteristics is limited, and the true population-
based, age-related incidence is not known. Furthermore, the
features which distinguish bacteraemic Campylobacter patients
from patients with acute Campylobacter gastroenteritis and a
concomitant negative blood culture have been poorly
described. We reviewed a large cohort of unselected
patients with proven invasive campylobacteriosis and present
the clinical and bacteriological characteristics.
Materials and Methods
Setting
During the 10-year study period, 1995 through 2004, the three
counties of Aarhus, Funen and North Jutland had a mean of
1 601 675 residents (30.1% of Denmark’s population). The
Danish public health system is tax ﬁnanced and free of charge
for all residents. All residents of the three counties in whom
an infectious disease was suspected were admitted to the
nearest hospital, or in more complicated cases, to the univer-
sity hospital within their county. Thus, the entire population
of the three counties served as the background population.
Microbiological procedures
Blood cultures. All blood cultures were carried out in a cen-
tralized laboratory in each of the three counties: Aarhus Uni-
versity Hospital (Aarhus County), Odense University
Hospital (Funen County) or Aalborg Hospital (North Jutland
County). During the study period, different procedures were
used which included the use of two or three bottles per
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sample (except for smaller children, for whom only one
sample bottle was used). In North Jutland County, until
December 1995, the Colorbact system (Statens Serum Insti-
tut, Copenhagen, Denmark) was in use, after which it was
replaced by the BacT/Alert system (bioMerieux, Durham,
NC, USA) with a nominal volume of 30 mL. In Aarhus
County, the BacT/Alert (bioMe´rieux, Marcy l’Etoile, France)
with a nominal volume of 2 · 20 mL was used throughout
the study period. In Funen County, until 2004 the ESP sys-
tem (Trek Diagnostic Systems, Cleveland, Ohio, USA) was in
use, after which it was replaced by BACTEC (BD, Franklin
Lakes, NJ, USA) with a nominal volume of 2 · 20 mL.
Faecal cultures. Bacteriological examination of faecal speci-
mens was carried out the by the Statens Serum Institut,
Copenhagen or at the Department of Clinical Microbiology
in Aalborg (from 1998) and in Aarhus (from 2003).
Identiﬁcation. Presumptive identiﬁcation of Campylobacter iso-
lates was based on colony morphology, wet smear, Gram
stain and oxidase and catalase reactions (both positive). Iso-
lates of C. jejuni and C. coli were not routinely differentiated.
Blood culture isolates were referred to the Statens Serum
Institute for species diagnosis.
Antimicrobial susceptibility testing was performed using a
disk diffusion method (Neo-Sensitabs; Rosco, Taastrup, Den-
mark) on Danish horse blood agar or Mueller–Hinton II agar.
Data retrieval
The Danish personal identiﬁcation number was the unique
key used for each patient and linkage between registries. To
identify the study cohort, data were retrieved electronically
by linkage to the laboratory information system of each of
the participating departments of clinical microbiology.
Patients were linked to the National Registry of Hospital
Discharge Diagnoses coded according to the International
Classiﬁcation of Diseases 10, and the Central Population Regis-
try (with the status alive or dead, and, in the latter case, date
of death). As Campylobacter bacteraemia is very rare, we
compared it with the characteristics of patients admitted to
hospital for sepsis from 1996 through 2004, where a blood
culture taken on admission was negative and where a stool
culture indicated Campylobacter enteritis. These patients
were at risk of invasive campylobacteriosis and had clinical
symptoms severe enough to warrant a blood culture on
clinical grounds. For calculations of incidence rates, the
numbers of residents in the three counties were retrieved
from a databank [10], using a population categorized by
age (integer years) as of 1 January for each of the years
1995–2004.
We reviewed all medical records to obtain data on coexis-
ting disease, exposure, travel history, clinical picture and
medicine given during hospitalization. The Charlson index
[11] was used to categorize comorbid diseases (with higher
scores associated with more severe disease categories), as
this index has proved its validity in several prognostic studies.
Statistical analysis
Incidence rates within 10-year age groups (ranging from 0–9
to >90 years) were calculated by summarizing populations
over the period 1995–2004 [10]. Annual incidence rates
within age groups were then calculated as numbers of bacter-
aemia patients per 1 000 000 person-years. The sampling date
(i.e. the date of the ﬁrst positive blood sample) was the start
event. Demographic and clinical characteristics were cross-
tabulated with the bacteraemia and enteritis patient groups.
Categorical data were compared using Chi-square or two-
sided Fisher exact tests and continuous data using the Mann–
Whitney test. A signiﬁcance level of 5% (p 0.05) was used in
all cases. STATA (Intercooled Stata 8.0 for Windows; StataCorp
LP, College Station, TX, USA) was used for all analyses.
Ethical considerations
The study was conducted according to guidelines of the Dan-
ish National Committee on Biomedical Research Ethics and
approved by the Danish Data Protection Agency (record no.
2004–41–4004).
Results
A total of 46 patients with Campylobacter bacteraemia were
identiﬁed in our population. The incidence was approxi-
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FIG. 1. Patients with Campylobacter bacteraemia in North Jutland,
Aarhus and Funen Counties, Denmark, 1995–2004: numbers and
incidence rates per 1 000 000 person-years, classiﬁed by 10-year age
groups.
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mately 2.9 per 1 million person-years, but with marked dif-
ferences in age distribution (Fig. 1). We observed only one
case during childhood. The peak incidence was in the age
group >80 years. All bacteraemic patients were hospitalized
and the infection was community-acquired as all blood cul-
tures positive for Campylobacter were taken within 2 days
after hospital admission of the patients. The numbers of fae-
cal isolates in the three counties during 1995–2004 were
11 296, i.e. approximately 705 per 1 million person-years.
Thus, the estimated ratio between blood and faecal isolates
was 0.004. The bacteriological diagnoses of blood isolates
were C. jejuni in 37 patients, C. coli in ﬁve patients, C. fetus in
three patients and C. lari in one patient. Antibiotic suscepti-
bility of blood isolates was to erythromycin 37/40 (92.5%),
to gentamicin 17/18 (94%) and to ciproﬂoxacin 26/35 (74%),
whereas other agents not used in clinical practice were
rarely examined. From 102 patients with non-bacteraemic
enteritis, all isolates were reported as C. jejuni/coli.
Since the occurrence of Campylobacter bacteraemia is very
rare, we compared it with the characteristics of patients
admitted to hospital for sepsis. Acquisition of infection was
domestic in 84% of all cases, with no difference between
bacteraemia and enteritis groups. The bacteraemia patients
were older (median 56 years vs. 32 years) and had higher
comorbidity (one or more of the diseases implemented in
the Charlson index: 59% vs. 31%; p 0.006), Table 1. The
major comorbidities were cardiovascular disease (n = 11),
malignancy (n = 7), chronic obstructive pulmonary disease
(n = 4), HIV (n = 4), cerebrovascular insult (n = 4) and
diabetes mellitus (n = 3). Patients in the bacteraemia group
frequently had more problems with alcoholism (8% vs. 2%,
p 0.008), more previous major gastrointestinal surgery (12%
vs. 3%, p 0.005) and they were more often on immunosup-
pressive drug therapy (12% vs. 1%, p 0.002), Table 1. We
observed no differences between the two groups with
respect to baseline assessment of blood pressure, heart rate,
temperature, C-reactive protein, haemoglobin, leukocyte
count, creatinine or albumin.
By deﬁnition, all enteritis patients had diarrhoea, which
was present in only 27/46 (59%) of bacteraemia patients.
Antibiotic therapy was initiated on admission in 13 out of
19 (68%) bacteraemia patients without diarrhoea, in 14 out
of 27 (52%) bacteraemia patients with enteritis and in 42
(41%) enteritis patients (as a result of sepsis and clinical
suspicion of bacteraemia). Upon microbiological diagnosis,
antimicrobial treatment was initiated in 16 (35%) additional
bacteraemia patients, whereas three patients with Campylo-
bacter bacteraemia recovered without antimicrobial therapy.
A total of 21 patients were treated with a combination,
which included gentamicin. A secondary focus was docu-
mented in two cases. One patient had endocarditis which
was successfully treated and another patient had skin and
soft tissue infection in the lower right leg. The length of
hospitalization was signiﬁcantly longer in bacteraemia
patients, but the outcome was favourable with a low
mortality in both patient groups (Table 1). None of the
survivors was readmitted with Campylobacter infection
within the 365-day follow-up period, indicating that they
had all recovered.
Discussion
The ﬁndings in our population-based survey of invasive
Campylobacter infection conﬁrm that it is a rare disease with
a markedly skewed age distribution. It has been reported
that Campylobacter bacteraemia often occurs at the extremes
of age [5]. However, we detected only a single case in child-
hood, whereas the incidence increased considerably in the
age group >80 years. The reasons for the lack of positive
samples in infants remain speculative. The blood sample vol-
ume in small children is often critically low, and paediatric
bottles may not sustain growth of Campylobacter to the same
extent as ﬂasks for adult use. However, the afﬂuence of the
Danish society, the attention of parents to hygiene and the
high standard of drinking water in Denmark may also have
an impact on the epidemiology. Compared with the group of
hospitalized patients with sepsis as a result of Campylobacter
enteritis (but with negative blood culture) the median age
of bacteraemia patients was markedly higher. The ratio
TABLE 1. Demographic and clinical characteristics of
patients with Campylobacter bacteraemia and patients with
Campylobacter enteritis and a concomitant negative blood
culture, Aarhus, Funen and North Jutland counties, Denmark
1995–2004
Bacteraemia
(n = 46)
Enteritis
(n = 102)
Median age (range) 56 year
(1–94 years)
32 year
(1–85 years)
Gender %
females 28 41
males 72 59
Charlson-index
0 19 (41%) 70 (69%)
1–2 18 (39%) 19 (19%)
>2 9 (20%) 13 (12%)
Previous major gastrointestinal surgery 6 (12%) 3 (3%)
Alcoholism 4 (8%) 2 (2%)
Immunosuppressive drug therapy 6 (12%) 1 (1%)
Median length of hospitalization (range) 8 days
(1–113 days)
3 days
(1–29 days)
Mortality within
day 28 2 (4%) 1 (1%)
day 180 3 (6%) 1 (1%)
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between blood and faecal Campylobacter isolates in the popu-
lations studied over a 10-year period was 0.004, a ﬁgure that
may reﬂect both the invasiveness of the pathogen and the
frequency of positive bacteriological blood cultures in cases
of diarrhoea.
Tee and Wijch reported 1.6% cases of bacteraemia in
patients with Campylobacter enteritis [9], but this result was
obtained from a hospital-based study and not from the back-
ground population. Skirrow et al. reported a frequency of
0.15% blood isolates of the total national cases in the United
Kingdom [6], and during a survey in the United States the
extraintestinal sources accounted for 0.26% of all Campylo-
bacter isolates [12]. In any case, Campylobacter blood stream
infection is rare, and the incidence of 2.9 per 1 million
person-years is c. 1/10 the rate of invasive non-typhoid sal-
monellosis in our region [13]. Members of the genus
Campylobacter are micro-aerophilic and fastidious, and it is
possible that the type of blood culture system affects the iso-
lation rate. It is noteworthy that we detected Campylobacter
from blood with all four types of blood culture system used,
but most were observed with the Bact/Alert system. After a
change in methodology within the same institution, an
increase in the incidence of positive blood cultures for Cam-
pylobacter has been reported [9].
We also observed clear differences in clinical characteris-
tics between our two patient groups as expressed by the
Charlson index [10]. Patients with bacteraemia had consid-
erably more comorbidity as a risk factor, although this had
no negative impact as indicated by their low mortality. Tee
and Mijch found a ﬁve-fold increase of invasive Campylobac-
ter disease in subjects with human immunodeﬁciency virus
infection [9], and four of our patients had concomitant
HIV-infection. Comorbidity included more frequently major
disease categories such as cardiovascular disorders and
malignancies. The clinical presentation of Campylobacter bac-
teraemia was generally a mild, acute-onset febrile illness of
a transient nature with self-limiting enteritis. Initial reports
described Campylobacter bacteraemia predominantly in
enteritis patients [6]. However, the clinical picture of Cam-
pylobacter bacteraemia may show a febrile illness without
gastrointestinal symptoms [8], and 43% of our bacteraemic
patients did not report gastrointestinal symptoms. Travel
history was not a signiﬁcant risk factor, and most infections
were domestically acquired. In Denmark, the seasonal
occurrence of campylobacteriosis peaks in July–August, and
for bacteraemic patients a peak in the summer and early
autumn months has been reported as well [8]. We did not
observe any clear seasonal distribution in our bacteraemia
patients, which may suggest another pathogenesis for
invasive disease in comparison with the more common
acute gastroenteritis disorder. We previously reported a
similar disparity in seasonality for invasive vs. non-invasive
non-typhoid salmonellosis [14]. It is not clear if any bacterial
characteristics determine the invasiveness. Blaser et al. [5]
showed that bacteraemia in healthy subjects was usually
caused by serum-resistant isolates, and blood isolates from
Australia were predominantly of Penner serotype O:2 and
O:4;O:64 [9]. In contrast, blood isolates from England and
Wales were genomically heterogeneous and this suggests
that an invasive disease is not related to particular geno-
types [15].
Extraintestinal manifestations including cellulitis have been
described in Campylobacter bacteraemia [4,7], and we
detected one of these complications in our cohort. How-
ever, this patient did not have hypogammaglobulinaemia, the
most frequent association of this complication [4]. In immu-
nosuppressed patients, infection with Campylobacter may per-
sist for many months [9], but we did not detect any
recurrence or persistence in our cohort.
The mortality associated with Campylobacter bacteraemia
has been reported very differently, from 2.5% to 12.5%
[6–9]. In our cohort, the 28-day all-cause mortality was 4%,
which was considerably lower than for bacteraemias in
general. As a result of the very low invasiveness of Campylo-
bacter, we hypothesized that our bacteraemia patients could
possibly be frailer and less likely to survive than bacteremic
patients with more common bacteria, but our results
actually document a favourable outcome in the majority of
cases. The possibility of resistant strains must be considered
in all cases of Campylobacter bacteraemia. Immunosuppressed
patients in particular require more aggressive treatment with
a combination of antibiotics. Considering that 94% of our
isolates were susceptible to gentamicin in vitro, the treatment
regimen for Campylobacter bacteraemia should include am-
inoglycosides for severely ill patients. Previous surveys from
our region on bacteraemia with Campylobacter [7] did not
detect resistance to ciproﬂoxacin, but during the last decade
it has been increasingly recognized that ﬂuoroquinolone
susceptibility is no longer predictable for enteric pathogens
[16]. We now ﬁnd 26% of blood isolates resistant to
ciproﬂoxacin.
In conclusion, bacteraemia with Campylobacter species is
rare in Denmark, and the frequency is <1% of enteric Cam-
pylobacter infections. Patients with invasive campylobacterio-
sis are older and have higher comorbidity in comparison
with enteritis patients with a concomitant negative blood cul-
ture, but the outcome is generally favourable. As ﬂuoroqui-
nolone resistance is increasingly encountered, antimicrobial
chemotherapy for Campylobacter bacteraemia should include
an aminoglycoside.
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